In Brief
Dendritic cells (DCs) within the myocardium are poorly characterized. Clemente-Casares et al. demonstrate that the myocardium contains heterogeneous conventional DC subsets that differentially utilize recruitment and proliferation to maintain residency. They identify a BATF3-dependent CD103 + cDC surveillance system that prevents the transition of subclinical viral myocarditis to overt heart failure.
INTRODUCTION
Viral myocarditis is an important contributor to the development of cardiac dysfunction and its progression to heart failure (HF), a diagnosis that carries a 5-year mortality rate of > 60% (Ponikowski et al., 2014). Up to 40% of young individuals (< 35 years of age) with unexpected death have evidence of myocarditis (Dennert et al., 2008) . In addition, viral genomes have been detected in myocardial biopsies of a large proportion of individuals with idiopathic systolic (impaired contractile ability) or diastolic dysfunction (stiff and fibrotic cardiac tissue), but also in asymptomatic individuals (Bock et al., 2010; K€ uhl et al., 2005) . While viral clearance is associated with improved cardiac function, the persistence of virus does not predict HF development, suggesting that additional parameters contribute to host susceptibility. At present, the factors that govern transition of an otherwise innocuous cardiac viral infection that results in minimal (subclinical) injury to symptomatic HF are unknown. Conventional DCs (cDCs) are found patrolling various tissues, where they are critical in initiating anti-viral T cell responses. Initial strategies to identify these cells relied on CD11c (Dieterlen et al., 2016; Zhang and Zhang, 2010) , a prototypical DC marker that is also expressed by other myeloid cell types. Subsequently, the use of Zinc Finger and BTB Domain-Containing 46 (Zbtb46)-targeting strategies revealed a more narrow role for cDCs than previously appreciated (Meredith et al., 2012; Satpathy et al., 2012) . Despite substantial progress in identifying DCs across tissues and species (Guilliams et al., 2016) , very little is known about the identity of cardiac DCs and their role in the generation of antigen-specific immunity in viral myocarditis. One of the major difficulties in the study of cardiac DCs is related to cell abundance, and the challenge of distinguishing these cells from macrophages, an abundant cell population in the heart that shares numerous cell surface markers with DCs (Epelman et al., 2014a) . The majority of studies that focus on cardiac DCs relate to their role in transplantation tolerance and autoimmune myocarditis, situations where DC activation is clearly pathogenic (Blyszczuk et al., 2013; Leuschner et al., 2015) . Fewer studies have addressed the role of cDCs in viral myocarditis, and those that have, often used bulk manipulation or indirect inference where the study of transcription factors, adaptor proteins, viral sensors, and signaling molecules have been used to infer potential roles for cardiac DCs (Fairweather et al., 2003; Holm et al., 2010; McCartney et al., 2011; Valaperti et al., 2013) . Similarly, the priming of anti-viral CD8 + T cell responses during viral myocarditis is almost entirely uninvestigated due to the inability to identify and track viral-specific CD8 + T cells during infection. Together, these limitations might explain the lack of clarity regarding cardiac DC function (Anzai et al., 2012; Maekawa et al., 2009) . Recent studies have provided important insight into the development and origin of cDCs in the bone marrow (BM) (Guilliams et al., 2016; Miller et al., 2012; Satpathy et al., 2012; Sichien et al., 2016) , yet these avenues remain unexplored for DCs residing in the myocardium. This includes the relevance of newer concepts such as the pre-specification of cDC precursors (precDCs) occurring in the BM prior to release into the circulation Schlitzer et al., 2015) . Therefore, there are fundamental gaps in our understanding of adaptive immunity in the heart.
In this study, we identified a heterogeneous pool of cDCs within the myocardium, including two primary cDC subsets with distinct life cycles that differentially relied on local proliferation and recruitment of circulating pre-cDCs for their replenishment. We identified intermediate cDC subsets in cardiac DCs that were distinct from those characterized in the BM (Grajales- Schlitzer et al., 2015) and showed that C-C chemokine receptor 2 (CCR2) was required by cDCs to enter the myocardium, highlighting tissue-specific chemokine receptor usage. We also characterized the innate and adaptive immune responses in mice infected with the cardiotropic encephalomyocarditis variant-D virus (EMCV-D) and demonstrated a robust, monocyte-driven inflammatory response, with loss of reparative embryonic-derived (EmbryoD) cardiac macrophages following infection. We developed EMCV-D-specific MHC class I tetramers and observed that cardiac cDCs, specifically Basic Leucine Zipper Transcription Factor ATF-Like 3 (BATF3)-dependent CD103 + cDCs, were required to sense subclinical viral infection, generate EMCV-D specific CD8 + T cells, and prevent progression to HF. Taken together, our findings provide a conceptual framework for future investigations focusing on the innate and adaptive functions of cardiac cDCs. ), a subset that greatly expands during cardiac stress, also highly expressed CD11c, suggesting use of CD11c would fail to exclude all cardiac macrophage subsets ( Figure 1A ) (Epelman et al., 2014a; Lavine et al., 2014 Figure 1A ). Importantly, both subsets were not labeled by intravenous (i.v.) administration of an anti-CD45 antibody, indicating they resided within myocardial tissue ( Figure 1B ). We sorted both cardiac cDC1 and cDC2 subsets and compared them to CD11c -MHC-II hi cardiac macrophages (R1 in Figure 1A , referred to as MHC-II hi macrophages), a population capable of presenting antigen to T cells (Epelman et al., 2014a) . Visually, cardiac CD103 + and CD11b + DCs contained dendrites, while MHC-II hi macrophages did not ( Figure 1C )-similar to lung DCs and macrophages ( Figure S1B ). Figure 1D ). Both cardiac DC subsets shared common DC genes, including Zbtb46-a cDC-specific transcription factor Figure 1F ). Cardiac cDCs and macrophages differentially expressed surface markers that confirmed the gene-expression data (Figures 1G and S1C) .
RESULTS
To determine whether cardiac cDCs originated from definitive hematopoiesis, we performed genetic fate-mapping using Flt3-Cre: Rosa-mTmG mice, which constitutively express the Td Tomato reporter until definitive hematopoietic stem cells (HSCs) transiently pass through a FLT3 + stage, leading to a permanent switch from Td to GFP expression. In this system, we have termed cells derived from a definitive hematopoietic progenitor as Flt3-Cre + (Epelman et al., 2014a; Epelman et al., 2014b) . Both cardiac cDC subsets in adult mice derived from definitive hematopoiesis, while MHC-II hi cardiac macrophages derived from both Flt3-Cre + and Flt3-Cre À (embryonic) pathways (Epelman et al., 2014b; Hoeffel et al., 2015) ( Figure S1D and S1E), indicating cardiac cDCs were free of any contaminating, primitive macrophages. Similarly, administration of tamoxifen to pregnant females at E8.5 (prior to HSC formation) using an inducible system (Csf1r-mer-icre-mer, which expresses tamoxifen-inducible Cre under Csf1r promoter) (Epelman et al., 2014a; Yona et al., 2013) revealed no labeled cells in the adult progeny, whereas cardiac macrophages contained a sizeable number of labeled cells consistent with contributions from early embryonic hematopoiesis ( Figure S1F by MHC-II and CCR2 revealing three subsets (R1-R3). Representative flow cytometric plots are shown for cardiac DC and MF subsets (see Figure S1A for full gating). Expression of CD11c in cardiac MF subsets was detected using Itgax YFP/+ mice. Error bars represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. See also Figure S1 .
several complimentary approaches. To begin, we investigated the turnover of cardiac cDCs in a bromodeoxyuridine (BrdU) pulse-chase experiment. Cardiac cDCs were labeled by 4 daily injections of BrdU, and cDC subsets were analyzed after a chase period of 1, 3, or 17 days ( Figure 2A ). Cardiac cDC subsets were labeled comparably (day 1) and exhibited similar turnover (i.e., $30%-50% decline on day 3). The proliferation rate was assessed in mice pulsed with BrdU 2 hr prior to harvest (JongstraBilen et al., 2006) . CD103 + cardiac cDCs exhibited a significantly higher proliferation rate compared to CD11b + cDCs and MHC-II hi macrophages ( Figure 2B ), whereas proliferation of lung CD11b + and CD103 + cDCs was similar ( Figures S2A-S2C ).
Consistent with this, numerous genes required for proliferation were upregulated in CD103 + cDCs, while cell-cycle repressors were downregulated ( Figure 2C ). We then performed parabiotic studies to investigate the contribution of circulating precursors to cardiac cDC populations at 2 and 6 weeks post-surgery. At 2 weeks, significant chimerism was observed only in the CD11b + cDC population (normalized data - Figure 2D ; raw data Figure S2D) (D) CD45.1 and CD45.2 mice parabionts were surgically paired and chimerism within the myocardium was analyzed after 2 and 6 weeks. The percent tissue chimerism was normalized to blood monocyte chimerism (one experiment; N = 3-12). Error bars represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. See also Figure S2 .
cardiac cDC subsets declined 3 days post poly I:C administration and returned to steady-state levels after day 14 ( Figures  S2E and S2F ), similar to lung cDCs, indicating cardiac cDCs respond effectively to inflammatory stimuli. In summary, these data indicated that while cardiac cDC subsets turned over at similar rates, individual subsets preferentially utilized different mechanisms involving in situ proliferation versus recruitment from the blood.
CCR2 Maintains Cardiac cDCs but Not Other Tissue cDCs
Gene-expression analysis of sorted cardiac cDC and macrophage subsets demonstrated specific patterns of chemokine receptor usage, which might regulate cDC homeostasis or homing of precursors ( Figure 3A ). Both cardiac cDC subsets express Ccr2 and its genetic deficiency resulted in reduced cDC numbers in the myocardium during steady-state (Figure 3B) , whereas the numbers of cardiac MHC-II hi macrophages ( Figure 3B ) and lung, liver, and kidney cDCs (Figures 3C and S3A) were comparable to Ccr2-sufficient mice. This was confirmed in a separate Ccr2-deficient line (Ccr2 GFP/GFP , Figure S3B ). Heart and lung cDCs of Ccr2 À/À and Ccr2 +/+ littermates showed similar proliferative rates ( Figures 3D and 3E Grajales-Reyes et al., 2015) or CD117 and CD24 (Schlitzer et al., 2015) . We first confirmed complementarity between these strategies ( Figure S3C and S3D) and utilized Ly6c and SiglecH to demonstrate that blood pre-cDC chimerism rates in our parabiotic recipients were not affected by Ccr2 deficiency ( Figure S3E ). At 6 months post joining, we observed that Ccr2 +/+ CD103 + and Ccr2 +/+ CD11b + cDCs were able to preferentially establish chimerism within cardiac tissue over Ccr2 À/À cDCs in the recipient mouse ( Figures 3H-3I ). Collectively, our data support a cardiac-specific and cell-intrinsic role of CCR2 in the recruitment of pre-cDCs to the heart and in the establishment of both CD11b + and CD103 + cDCs subsets during steady-state and following cDC depletion. CX3CR1 has been described as an important regulator of tissue resident cDC numbers in several organs, such as lungs, kidneys, and intestines (Hochheiser et al., 2013; Jakubzick et al., 2008; Tamoutounour et al., 2012) . However, in contrast to the reduction observed in other organs, Cx3cr1-deficiency did not affect cDC composition in the heart ( Figure S3F ), which further highlights the distinct chemokine-receptor-based regulation of cardiac cDCs relative to other tissues. These studies identify CCR2 as a key, tissue-specific regulator of cardiac cDC homeostasis.
The Myocardium Contains Heterogeneous Subpopulations of cDCs DC heterogeneity is an important and underestimated concept in DC biology. Unbiased single cell RNA-sequencing and highdimensional analyses have revealed CD26 as a bona fide cDC marker across species (Guilliams et al., 2016) . In comparison to cardiac macrophages, CD26 (Dpp4) gene expression was markedly increased in cardiac CD11b + and CD103 + cDCs, as well as splenic cDC and BM pre-cDC subsets ( Figure S4A ). We confirmed CD26 protein expression on mature cardiac cDCs and not on cardiac macrophages ( Figure 4A ). To better understand cardiac DC heterogeneity, we gated inclusively on total CD45 + CD26 + cells ( Figure 4B ) and utilized multi-dimensional reduction analysis to provide unbiased clustering of our single cell flow cytometric data using unique t-distributed stochastic neighbor embedding (t-SNE) coordinates (Amir el et al., 2013) . T-SNE analysis revealed 8 population clusters within the CD45 + CD26 + gate ( Figure 4B ). Some subsets did not express common DC markers, such as CD11c, suggesting they might not be DCs ( Figure 4C ). We performed additional inclusive gating (CD45 + CD26 + CD11c lo-hi MHC-II lo-hi ) prior to applying the t-SNE analysis ( Figure 4D ) and only 5 clusters remained, including CD103 + (Pop #1) and CD11b + (pop #2) cDCs, which represented the majority of cardiac cDCs.
By using this unbiased approach, we observed two clusters (#3 and #6) grouped in-between the main cDC populations. These presumptive cDCs lacked expression of the mature DC markers CD103 and CD11b, and thus, we referred to them as double-negative (DN) cDCs ( Figure 4E ). We confirmed that DN cDCs were extravascular rather than DCs in circulation ( Figure S4B ). Gene-expression analysis indicated that mature cardiac CD103 + and CD11b + cDCs and their BM precursors expressed XCR1 and CD172a (SIRPa), respectively ( Figure S4C ). Both cardiac DN cDC subsets also expressed these markers (cluster #3: XCR1 + CD172a À versus cluster #6 CD172a Figure 4C ), however expression (as measured by the mean fluorescence intensity) of each was lower than in their respective mature cardiac cDC counterpart in the heart (Figure 4F) , which was similar to DN cDCs in the lung and liver ( Figure S4D ). We also identified a second CD11b + cDC population (cluster #4), that expressed intermediate levels of CD64, and functionally, possessed a proliferative capacity similar to CD64 À CD11b + cDCs, suggesting additional CD11b + (cDC2) heterogeneity ( Figure 4G ). CD11b + CD64 int cDCs and DN DCs both expressed ZBTB46 and CD26, and thus appeared to be bona fide cDCs ( Figure 4H ). Similarly, DN DCs in the lung and liver also expressed ZBTB46 ( Figure S4E ). A similar CD103 À CD11b À DN population was recently identified within solid tumors (Salmon et al., 2016) and was suggested to represent an immature, tumor-associated, cDC1 stage. Our data indicated that bona fide DN cDCs grouped as cDC1-like (XCR1 + ) and cDC2-like (CD172a + ) across tissues. To ascertain whether our CD103 (F and G) CD45.1 irradiated mice were reconstituted with an equal ratio of BM from either (Ccr2
CD45.2 Rosa-Td) mice (performed once; N = 5 each). Flow cytometry of the mixed BM chimera recipient mouse is shown 3 months after reconstitution (F). Ratio of cDCs that originated from either Ccr2
is graphed in the heart (top) and lung (bottom) (done once; N = 5 each).
(H and I) Ccr2 À/À recipient parabionts were either paired to WT Rosa-Td mice (above) or Ccr2 À/À Rosa-Td mice (below) for 24 weeks (performed once; N = 5-6).
The recipient (Td À ) mouse was analyzed, and the ratio of donor derived (Td + ) cDCs is shown by flow cytometry (H), and averaged data normalized to the pre-cDC frequency (gated as in Figure S3C ) in blood at the time of harvest (I). Error bars represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001; A-I). See also Figure S3 . (legend continued on next page) XCR1 + DN DCs was significantly higher than that of CD172a + DN DCs ( Figure 4I ), similar to their respective mature cardiac cDC subsets ( Figure 2B ). Cardiac CD103 + cDCs expressed the transcription factors Batf3 and Irf8, and genetic ablation of either led to a complete loss of cardiac CD103 + cDCs, with negligible effects on CD11b + cDCs ( Figure 4J ). XCR1 + DN cDCs were completely lost in Batf3 À/À and Irf8 À/À mice, while DN CD172a + cDCs were only mildly affected ( Figure 4K ). Both XCR1 + and CD172a + DN cDCs expressed cell surface markers in a similar fashion to their respective mature cDC counterparts in the heart ( Figure 4L ), and the lung ( Figure S4F ). FLT3L intraperitoneal (i.p). administration increased DN cDCs and mature cDCs within cardiac tissue ( Figure 4M ). We then separately sorted DN CD172a + and XCR1 + cDCs and cultured them individually with chimeric BM feeder cells ( Figure S4G ), detecting increased CD103 expression on XCR1 + DN cDCs and increased CD11b expression on CD172a + DN cDCs, which demonstrates that DN cDCs had the capacity to upregulate cell surface markers expressed on more mature cDCs. The heart and lung XCR1 + and CD172a + DN pre-cDC subsets we identified fell into the CD11b À CD24 int-hi gate ( Figure S4H ), and thus do not appear to be the KLF4-dependent migratory ''double negative'' DC subsets recently identified in skin draining lymph nodes . Additionally, heterogeneity was observed in the differential expression of CD24 on CD11b + CD64 À cDCs; however, this was not related to differential ZBTB46 expression or proliferative capacity ( Figures S4I  and S4J ). These data suggest that DN (CD103 À CD11b À ) cDCs reside in a variety of organs, including the heart. Our data supports and expands the notion of this population representing an intermediate stage of maturation and identifies XCR1 and CD172a as markers of cDC1 or cDC2 lineage commitment, respectively.
Viral Myocarditis Promotes a Temporary Recruitment of Myeloid Immune Cells with Permanent Changes in the Resident Macrophage and cDC Populations
In order to study the role of cardiac cDCs in the pathogenesis of viral myocarditis we utilized the EMCV-D model (Liu et al., 2000; McCartney et al., 2011) . EMCV-D is a cardiotropic RNA picornavirus similar to the human pathogen Coxsackie virus B (CVB3); however, unlike CVB3, it does not cause relapsing infection and this strain of EMCV-D replicates in the heart of C57BL/6 mice. Following i.p. inoculation, virus was detected in the heart by qPCR on day 2, peaked on day 7, and could not be detected by day 28 ( Figure 5A ). Flow cytometric analysis revealed decreased cardiac cDCs on day 4, particularly the CD11b + subset, followed by a large increase in both subsets ( Figure 5B ). The proliferation rate of the CD103 + subset markedly increased on day 7, while CD11b + cDC proliferation declined modestly ( Figure 5C ), suggesting distinct regulatory mechanisms. We observed a reduction in ZBTB46 expression in CD11b + cDCs at day 7, whereas its expression in CD103 + cDCs was unaffected ( Figure 5D ). Myocarditis-induced cDC dynamics occurred in the context of a complex innate immune response in which myeloid cells increased dramatically in the myocardium, peaking on day 7 ( Figures 5E and 5F ). This was driven by an inflammatory response predominated by the recruitment of Ly6c hi MHC-II lo CD64 lo monocytes that differentiated into Ly6c + CD64 + MHC-II + tissue macrophages (Figures 5E and 5F and S5A and S5B) . The magnitude of the monocyte and macrophage expansion in the myocardium over the course of the infection was striking, in contrast to small changes in neutrophil and NK cell numbers ( Figures 5F and S5A ). Like cDCs, macrophages reside in normal myocardium, and we have previously used genetic fate mapping to define distinct macrophage subsets, origins, and functions (Epelman et al., 2014a; Epelman et al., 2014b) . We used the Flt3-Cre:RosamTmG mouse line to show that reparative resident EmbryoD macrophage (Flt3-Cre À Ly6c À ) (Lavine et al., 2014 ) numbers were reduced on day 7 of myocarditis and partially recover by day 28 (Figures 5G-5I ). In contrast, HSC-derived (HSCD) monocytes and macrophages (Flt3-Cre + ) were increased 8-fold on day 7 and 2-fold on day 28 ( Figures 5G-5I ). These recruited macrophages were enriched in the proinflammatory CCR2 + macrophage subset ( Figure 5J ). These data provide a phenotypic and ontogeny-based map of the evolving innate immune response to viral myocarditis. EmbryoD macrophage depletion during viral myocarditis contrasts to their numerical expansion during hypertensive stress (Epelman et al., 2014a) and highlights how macrophage composition can change depending on the type of cardiac injury. Figure 6A ). VP2 is a highly conserved Picornavirus capsid protein, and tetramers specific for the VP2-derived peptide (121-130) have been used to study other Picornaviruses (Johnson et al., 1999) . In EMCV-D-infected mice, VP2-specific CD8 + T cells could be first identified by day 4 in the thoracic lymph node (LN), which drains the thoracic organs ( Figures 6B and 6C and S6A), but not in remote areas, such as popliteal and mesenteric LNs ( Figure 6D ). VP2-specific CD8 + T cells were highly proliferative, especially early after infection ( Figures 6B and 6C ). VP2-specific CD8 + T cells could be detected in the blood and heart by day 7 (Figures 6E and 6F ). The fact that $30% of heart CD8 + T cells were labeled by the VP2 tetramer suggests that the VP2 121-130 peptide was immunodominant and promoted the highest levels of CD8 + T cell proliferation in LNs and the myocardium ( Figures 6F and 6G ). Infiltrating cardiac CD8 + T cells produced significant amounts of the pro-inflammatory cytokines IFN-g and TNF-a, indicating they were functional (Figure S6B ). While we could not follow EMCV-D-specific CD4 + T cells, we observed a large infiltration during infection, with substantial numbers of CD4 + T cells also proliferating (Figure 6H) . The responses were dose-dependent, with higher EMCV-D doses inducing a greater percentage of VP2 + CD8 + T cells in the blood; however, the absolute number and the percentage of VP2-specific CD8 + T cells within the myocardium remained similar at high doses ( Figures S6C and S6D ). We confirmed myocardial T cells resided in extravascular tissue ( Figure S6E) .
Viral Myocarditis Promotes the
After a viral infection, tissue-resident CD8 + T cells are formed and retained at the site of infection in numerous tissues (Gebhardt and Mackay, 2012) , but this has not been assessed in myocarditis. On day 56, after viral clearance and resolution of cardiac inflammation ( Figures 5A and 5E ), we observed maintenance of EMCV-D-specific memory CD8 + T cells in the heart, spleen, and BM ( Figures 6I-6K ). Tissue-resident memory CD8 + T cells in the heart were almost exclusively VP2-specific ($70%-80%), as compared to the spleen ($2%) and BM ($6%), with the majority expressing effector memory markers (CD62L À CD44 + ) ( Figures 6I-6K ). The use of tetramers enabled us to track the regional initiation of the EMCV-D-specific CD8 + T cell response in the thoracic LNs and the subsequent release and infiltration of EMCV-D specific CD8 + T cell into the blood and myocardium. Ultimately, the initial expansion of EMCV-D specific CD8 + T cells led to the generation of virus-specific memory CD8 + T cells in lymphoid organs and a resident population, within cardiac tissue.
Conditional Depletion of ZBTB46-Expressing cDCs Impairs Generation of Antigen Specific-CD8 + T Cells during Viral Myocarditis
We chose Zbtb46 DTR/DTR mice to specifically deplete cDCs. This added an additional level of specificity over traditional approaches using CD11c for depletion (Itgax-DTR) (Meredith et al., 2012) , and is important given the robust infiltration of CD11c + CCR2 + cardiac macrophages during EMCV-D infection ( Figure 5J ). In control experiments (without depletion), there was no effect on total cDC numbers, generation of VP2-specific ) by $70%-90% and had no effect on cardiac macrophages ( Figures S7D and S7E ).
All cDC-depleted mice survived EMCV-D myocarditis, in contrast to previous studies using Itgax-DTR mice (McCartney et al., 2011) indicative of a more restrictive phenotype. In cDCdepleted mice, cardiac CD103 + cDC numbers remained low on day 7 post-EMCV-D infection, whereas CD11b + cDCs were reduced by $50% (Figure 7A ), consistent with their lower expression of ZBTB46 during infection ( Figure 5D ). This correlated with a dramatic reduction in VP2-specific CD8 + T cells on day 7 in the blood and myocardium ( Figure 7B ) and focal areas of severely impaired left ventricular systolic function ( Figure 7C ). Depletion of cardiac cDCs, in particular CD103 + cDCs, was associated with impaired VP2-specific CD8 + T cell generation ( Figure 7D ) implicating a prominent functional role for the CD103 + subset. These data suggest that, despite the capability of macrophages and other cells to express MHC-II and present Figure 4J , Figure S7F ). Over a 56-day post-inoculation interval, the abundance of VP2-specific CD8 + T cells in the blood of Batf3 À/À mice was markedly reduced relative to WT mice ( Figure 7D ). On day 7 post-infection, total and VP2-specific CD8 + T cells were substantially reduced in the hearts of Batf3 À/À mice (Figure 7E) . The absolute number of proliferating VP2-specific CD8 + T cells was also reduced in the heart of Batf3 À/À mice;
however, the percent of proliferating cells was comparable ( Figure 7F ), suggesting that a similar proliferative program is triggered in T cells upon accumulation in the myocardium. Batf3
mice had fewer infiltrating monocytes and neutrophils (Figure S7G) , suggesting that the absence of CD103 + cDCs blunts the amplification of the innate immune response. EMCV-D-infected WT mice exhibited only minimal cardiac fibrosis and also minimally impaired cardiac function, indicating subclinical cardiac infection with EMCV-D (Figures 7G and 7H ). With the same subclinical dose, loss of BATF3-dependent CD103 + cDCs led to significant cardiac fibrosis and cardiac dysfunction, suggesting that CD103 + cDCs are required to prevent transition from subtle injury to overt HF ( Figures 7G and 7H) . We confirmed the essential role of adaptive immunity to control acute EMCV-D infection by infecting Rag1 À/À mice, which lack T and B cells.
These mice developed left ventricular dysfunction, increased viral loads and significant mortality following EMCV-D infection ( Figures S7H-S7J ). In summary, our data suggest BAFT3-dependent CD103 + cDCs are essential to generate antigen-specific CD8 + T cell responses and prevent the development of HF during an otherwise mild viral infection.
DISCUSSION
Organ-and disease-specific cDC and T cell functions have been characterized in numerous tissues, but detailed characterization of these subsets in the heart has been lacking. Given the important etiologic role of viral myocarditis to the pathogenesis of HF, we sought to identify, characterize, and unravel the functional relevance of cardiac cDCs, including their ability to elicit antigen-specific CD8 + T cell responses.
Recent studies have revealed increasing heterogeneity underlying precursor, circulating and tissue cDCs (Becher et al., 2014; Guilliams et al., 2016; Menezes et al., 2016; Schlitzer et al., 2015) . Our analyses suggest the heart contains at least 5 CD26 + ZBTB46
+ cDC subsets, including two cDC1 and three cDC2 populations. The most abundant, and also best described across tissues were cardiac cDC1 (CD103 + XCR1 hi ) and cDC2 (CD11b + CD172a hi ) subsets. We also identified a CD64 int population of CD11b + cDC2, which is consistent with prior studies indicating that CD64 is expressed not only by monocytes and macrophages, but also by some tissue cDCs (Guilliams et al., 2016) . An important remaining challenge is differentiating monocyte-derived DCs, which can express CD64 (Plantinga et al., 2013) , from bona fide cDCs, which can also express CD64. Recent work has defined a subset of circulating monocytes that give rise to CD11b + ZBTB46 Neg DCs (Menezes et al., 2016) . In the setting of cardiac inflammation, cardiac CD11b + cDCs continue to express ZBTB46; albeit at lower levels than in steady state. Further studies are required to define the exact nature of CD11b + cDCs during inflammation.
cDCs specify cell-fate decisions (pre-cDC1 versus pre-cDC2) in BM and retain some cell surface markers upon release into circulation Schlitzer et al., 2015) . XCR1 and CD172a have been used to dichotomously classify cDC1 and cDC2, as have CD103 and CD11b. However, imprinting of these and other markers is variable between tissues, and also in anatomical microenvironments within a single tissue, which contributes to cDC heterogeneity (Guilliams et al., 2016) . Within the total cDC pool, we identified DN cDCs that lacked expression of both CD103 and CD11b. Identification of DN cDCs was not cardiac-specific, but these subsets were found in other organs suggesting that DN cDCs might represent an intermediate population between circulating pre-cDCs and mature tissue cDCs. Our observations in the steady state are consistent with a prior study in the inflammatory microenvironment of the solid tumor, where tumor-associated CD103
À

CD11b
À cDCs were also identified, shown to be FLT3L responsive, and could upregulate CD103 after culture in vitro (Salmon et al., 2016) . Our data suggest that this intermediate stage occurs for both cDC1 and cDC2 types, and the committed precursors can be segregated based on their expression of XCR1 and CD172a. The signals that promote cDC maturation in tissue are not well understood, nor is the functional significance of heterogeneity within the cDC1 and cDC2 subsets. Cardiac cDCs have specific life cycles and properties that we did not observe in other tissue cDC populations. For example, cardiac cDCs are partially CCR2-dependent, while lung, kidney, and liver cDCs are not. cDC proliferation, coupled with retention of loaded MHC molecules in daughter cells, could allow for antigen-presentation beyond the cDC life-span, suggesting why cross-presenting cardiac CD103 + cDCs might choose this strategy (Liu et al., 2007) . Moreover, the use of CCR2 for cell intrinsic cDC recruitment into the heart raises clinically relevant questions. Several studies have reported improved cardiac function in models of experimental autoimmune myocarditis or myocardial infarction when CCR2 or its ligands were neutralized, with the idea that CCR2 + monocytes were the key target (Frangogiannis et al., 2007; Gö ser et al., 2005; Kaikita et al., 2004; Leuschner et al., 2015) . These experimental models can be highly dependent on cDCs or could involve innate DC functions, suggesting a need to revisit the contributions of CCR2 + cDCs versus CCR2 + monocytes in these models now that we have the tools and understanding to separate their roles.
Myocarditis is responsible for 10%-15% of all HF cases worldwide and is one of the most common reasons for heart transplantation because specific treatments are lacking (Sagar et al., 2012) . Although there is a high prevalence of prior viral infection in patients who develop non-ischemic HF, many individuals who have evidence of prior viral cardiac infection never develop HF (Bock et al., 2010; K€ uhl et al., 2005) . Unlike other tissues, very little is known about how an adaptive immune response in the heart is generated, and what cell types are required to prevent the progression of viral. We defined the importance of a BATF3-dependent CD103
+ cDC viral surveillance system in a clinically relevant, subclinical cardiac infection model, one that resembles an innocuous and self-limiting viral infection that is much more prevalent in the population than fulminant viral myocarditis (Kindermann et al., 2012) . Specifically, we showed that with subclinical viral myocarditis, either specific depletion of cDCs using Zbtb46-DTR mice or loss of BATF3-dependent CD103 + cDCs led to impaired generation and infiltration of EMCV-D-specific CD8 + T cells, increased cardiac injury and transition to HF, without leading to mortality. Specific cDC targeting revealed a clear role for CD103 + cDCs in preventing cardiac dysfunction, rather than preventing systemic injury and death, while prior studies using a more broad, Itgax-DTR based approach, resulted in significant mortality (McCartney et al., 2011) . This is similar to the clinical picture, where viral myocarditis in patients rarely causes mortality, but can cause significant morbidity (Sagar et al., 2012) . Our study defined the origin, life cycle, and functions of cardiac cDCs, and developed the tools to study the role of cDCs in the generation of antigen-specific CD8 + T cell during viral myocarditis. Our observations highlighted differences between cardiac and other tissue cDC subsets and revealed an absolute requirement for BATF3-dependent CD103 + cDCs to prevent the transition from subclinical myocarditis to HF. While this observation was context-specific (subclinical infection), it is clinically relevant. Additionally, we present a framework for future investigations into the specific role cardiac cDCs play in both infectious and sterile cardiac injury.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
STAR+METHODS CONTACT FOR REAGENT AND RESOURCE SHARING
EXPERIMENTAL MODEL AND SUBJECT DETAILS
6-20 week old male and female mice were used. C57BL/6J mice were purchased from The Jackson Laboratory. Mice were bred in our animal facility prior to use. Cx3cr1 GFP/+ mice were kindly provided by Dr. Daniel Link (Jung et al., 2000) . Zbtb46 GFP/+ and Irf8 BXH2/BXH2 mice were provided by Dr. Kenneth Murphy and have been previously described (Edelson et al., 2011; Qi et al., 2009; Satpathy et al., 2012; Tailor et al., 2008; Xu et al., 2012) . Flt3-cre mice were a kind gift from Dr. Thomas Boehm and were crossed with Rosa-mTmG C57BL/6 reporter mice (Jackson) (Boyer et al., 2011) . Ccr2 GFP/+ mice were generated by insertion of GFP under control of the native CCR2 promoter (Satpathy et al., 2013) . Csf1R-Mer-iCre-Mer mice were provided by Dr. Jeffry Pollard (Qian et al., 2011) and were crossed with the Rosa-mTmG reporter. Tamoxifen (2 mg) was gavaged in 100 ml of corn oil at E8.5 to label yolk sac MFs Schulz et al., 2012) . Batf3 À/À and Zbtb46 DTR/DTR mice were purchased from The Jackson Laboratory. Irf8 À/À mice were a kind gift from Dr. Deepta Bhattacharya (Becker et al., 2012) and separately purchased from The Jackson Laboratory. Rag1 À/À mice were kindly provided by Dr. Daniel Winer. CD45.1 mice were purchased from The Jackson
Laboratory. All mice were bred and maintained at University Health Network and experimental procedures were done in accordance with the animal-use oversight committees.
METHOD DETAILS Tissue Isolation
Mice were euthanized by CO 2 fixation. Hearts were then perfused with 20 mL of cold PBS. Hearts, lungs, and livers were minced finely and digested with shaking for 1 hour at 37 C in DMEM containing collagenase I (450 U/mL), DNase I (60 U/mL), and hyaluronidase (60 U/mL) enzymes (all Sigma). EMCV-D infected samples were digested with Collagenase D (125 U/mL, Roche), DNase I and hyaluronidase for 60 minutes at 37 C. The digested material from heart, lungs and livers was filtered through 40 mm filters and pelleted by centrifugation (400xg for 5 minutes at 4 C) in HBSS supplemented with 2% FCS + 0.2% BSA. Liver was filtered and resuspended into 40% Percoll. Brain was filtered and resuspended into 40% Percoll mixed over top 80% Percoll, and centrifuged for 30 min. Spleens were removed, minced and triturated through 40 mm filters in HBSS. Blood was collected into heparinized syringes. Red blood cells were lysed in ACK lysis buffer (Lonza) for 5 minutes at room temperature, and then resuspended in FACS buffer (PBS containing 2% FCS and 2 mM EDTA). Single-cell suspensions were then stained for cell-surface markers using antibodies listed in the Gating Strategy and Antibodies section.
Flow Cytometry
Single cell suspensions were labeled with antibodies (0.2ml/sample) for 30 min at 4 C and washed in FACS buffer. All flow cytometric analysis was done on either an LSR Fortessa or FACS Canto II. After gating on CD45 + cells, doublets were excluded and live cells were analyzed using FSC/SSC live-dead exclusion. Single cell analysis software (FlowJo) was used to analyze cell cytometric data. Full gating strategy of cardiac cDCs is shown in Figure 1A and S1A. Gating strategy for pre-cDCs is shown in Figure S3C . Gating strategy for DNs cDCs is shown in Figure 4E . BrdU: For proliferation experiments, 2 mg of BrdU (Sigma) was injected i.p. 2 hours prior to harvest and for BrdU pulse-chase labeling experiments, 2 mg of BrdU was injected daily for four days and chased for the indicated time points . To detect intracellular BrdU, the BD Bioscience Cytofix/cytoperm technique was used. Briefly, cells were fixed after cell surface staining as above, DNA was digested for 1 hour with DNase (Sigma), and then samples were labeled with anti-BrdU antibody.
Gating Strategy
RNA Isolation and qPCR RNA was isolated from homogenized tissue using Trizol Reagent (Ambion) and the RNeasy Micro Kit (QIAGEN) as per manufacturer's instructions. Samples were digested with DNase (QIAGEN) prior to reverse transcription using the iScript cDNA synthesis kit (BioRad) using 800ng of RNA. The resultant cDNA was analyzed by qPCR using LightCyclerÒ 480 SYBR Green I Master Mix in a Roche LightCycler (Roche). [HRPT (forward: 5 0 -CAAGCTTGCTGGTGAAAAGGA À3 0 ; reverse: 5 0 -TGAAGTACTCATTATAGTCAAGGGCA TATC À3 0 ) ; EMCV (forward 5 0 -GTCGTGAAGGAAGCAGTTCCTC-3 0 ; reverse 5 0 -CACGTGGCTTTTGGCCGCAGAGG-3 0 )]. For absolute quantification, a standard curve of known concentration for EMCV was generated, as well as for HPRT to normalize for amount of RNA added to qPCR plate wells.
Cell Sorting for Microarray
Cell sorting was performed using AriaII instrumentation (BD Bioscience). To sort cDCs and MFs, we altered our digestion protocol to minimize activation. Minced cardiac tissue was digested for only 45 minutes in Collagenase D (Roche) and DNase I (in tissue isolation section of Supplemental methods section). RBCs were lysed for 3 minutes. Cells were gated on live (DAPI -) and gated as described in Gating strategy and antibodies section. All samples were sorted directly into either RPMI + 50% bovine serum for cell visualization studies or into RLT buffer for RNA extraction (QIAGEN).
Cell Sorting and Culturing for DN Maturation
Lungs from Flt3-cre Rosa-mTmG mice were digested as explained in Tissue Isolation section and sorted for XCR1 + and CD172 + DNs.
Sorted cells were separately co-cultured in 2x10 4 BM cells from C57BL/6 mice in 96 well plates. CD11b and CD103 gMFI expression was analyzed immediately after sort (Day 0) and 24 hours with 100 ng Flt3 ligand treatment (Day 1).
CD45 Bead Enrichment
Tissue was harvested and digested as described in Tissue Isolation section. Single-cell suspension was stained with CD45 MicroBeads (Miltenyi Biotec) for 15 minutes. Cells were positively selected with autoMACS and stained in FACS buffer with antibodies as described in Flow cytometry, antibodies, and gating strategy section.
Cell Visualization
To visualize DC and MF morphology, hearts or lung were harvested and digested as described in Tissue Isolation section. Prior to sorting, cells were enriched for CD45 + cells using CD45 MicroBeads (Miltenyi Biotec) as described in CD45 Bead Enrichment section. Heart tissue was sorted for MHC-II hi MFs, CD103 + DCs and CD11b + cDCs. Lung tissue was sorted for alveolar MFs, CD103 + DCs and CD11b + cDCs. Cells were centrifuged in a Cytospin centrifuge (800rpm, 5min, Thermo Shandon Cytospin 3) onto gelatin coated Cytospin slides. The slides were air-dried and dehydrated with À20 C methanol and then frozen in À80 C freezer. The frozen slides were then stained with Hematoxylin and eosin. Cells were imaged using an Olympus BX51 brightfield microscope with a 60x oil immersion lens (AOMF -Advanced Optical Microscopy Facility, Toronto, ON Canada). Approximately 20 cells were counted per cardiac or lung DC and MF subset.
Parabiosis
Briefly, after shaving the corresponding lateral aspects of each mouse, matching skin incisions were made from behind the ear to the tail of each mouse, and the subcutaneous fascia was bluntly dissected to create $0.5 cm of free skin. The olecranon and knee joints were attached by a mono-nylon 5.0 (Ethicon), and the dorsal and ventral skins were approximated by continuous suture as previously described . Mice were given Buprenorphine 0.1mg/kg after surgery. All animals received 3% neomycin antibiotics for 2 weeks. Figure 2: CD45.1 and CD45.2 mice were surgically joined to create parabiotic mice and were analyzed after 2 and 6 weeks as described previously . The percentage chimerism for each cardiac cDC and MF subset was normalized to blood monocytes in the recipient mouse (that originated from the donor) and expressed as a percentage. (% Normalized chimerism = % Donor cell in recipient / % Ly6c hi monocytes donor cells in recipient x 100). 
Echocardiography
Mouse echocardiography was performed using the VisualSonics VevoÒ 2100 System. 2D and M-mode images were obtained in the long and short axis views. Wall motion index score was calculated using the following scaling: 0 = normal contraction, 1 = hypokinesia, 2 = akinesia, 3 = dyskinesia) with 10 segments of each heart analyzed. Total number of abnormal segments calculated using standard techniques. Some mice developed heart block (second degree), which was given a score of either 0 or 1, a score of 0 indicating no arrhythmia, and a score of one 1 indicating a degree of heart block, which made the final number of segments = 11. Imaging was done by blinded individuals, as was the analysis.
QUANTIFICATION AND STATISTICAL ANALYSIS
Figures represent pooled data from independent experiments. Experiments were repeated at least twice, unless otherwise specified in the figure legends. All data are presented as mean ± SEM. Two-tailed Student's t test was used for comparisons between experimental groups. Significant differences were defined at p < 0.05. When necessary, adjustment for multiple comparison was utilized (FDR in gene expression array studies), or the Bonferoni correction.
DATA AND SOFTWARE AVAILABILITY
Cardiac DC and Macrophage microarray data were deposited into GEO (GSE102828).
